Literature DB >> 33754277

A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel.

Keivan Majidzadeh-A1, Shiva Zarinfam2, Nasrin Abdoli2, Fatemeh Yadegari2, Rezvan Esmaeili2, Leila Farahmand3, Azin Teimourzadeh2, Mahdieh Taghizadeh4, Mansoor Salehi5, Mohamad Zamani2.   

Abstract

BRCA1 and BRCA2 are two prominent genes that account for about 20-40% of inherited breast cancer. Mutations in these genes are often associated with clustering of especially early-onset cancers in the family. The spectrum of BRCA variants showed a significant difference between geographic regions and ethnicities. The frequency and spectrum of BRCA mutations in Iran, a country in southwest Asia, have not yet been thoroughly studied. Here, for the first time, all published and not published BRCA pathogenic variants are presented. Among 1040 high risk families (1258 cases) which were detected, 116 families were found to carry pathogenic variants in either BRCA1 or BRCA2. Altogether 89 distinct types of pathogenic variants have been detected in Iran, including 41 in BRCA1 and 48 in BRCA2. 16 out of 89 mutations had not been previously reported in Iran and are presented for the first time in this article, among which 4 mutations are novel worldwide. 20% of families had one of the seven most commonly observed mutations, including c.81-1G > C, c.66_67delAG, c.4609C>T, c.1568delT, c.1961delA, in BRCA1 and: c.3751_3752insA, c.8585dupT in BRCA2. Combining the data from published articles and our study which has not been published before, a comprehensive table is created as a reference for entire BRCA pathogenic variants and their frequencies in Iran.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  BRCA mutations; Hereditary breast cancer; Iran; Pathogenic variants

Mesh:

Substances:

Year:  2021        PMID: 33754277     DOI: 10.1007/s10689-021-00242-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  30 in total

1.  Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.

Authors:  Jing Zhang; James D Fackenthal; Yonglan Zheng; Dezheng Huo; Ningqi Hou; Qun Niu; Cecilia Zvosec; Temidayo O Ogundiran; Anselm J Hennis; Maria Cristina Leske; Barbara Nemesure; Suh-Yuh Wu; Olufunmilayo I Olopade
Journal:  Breast Cancer Res Treat       Date:  2012-06-28       Impact factor: 4.872

2.  Breast cancer in Iran: a review of 903 case records.

Authors:  I Harirchi; M Ebrahimi; N Zamani; S Jarvandi; A Montazeri
Journal:  Public Health       Date:  2000-03       Impact factor: 2.427

3.  The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.

Authors:  P Hartge; J P Struewing; S Wacholder; L C Brody; M A Tucker
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Authors:  Cynthia Villarreal-Garza; Rosa María Alvarez-Gómez; Carlos Pérez-Plasencia; Luis A Herrera; Josef Herzog; Danielle Castillo; Alejandro Mohar; Clementina Castro; Lenny N Gallardo; Dolores Gallardo; Miguel Santibáñez; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

6.  The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.

Authors:  Eunyoung Kang; Moon-Woo Seong; Sue K Park; Jong Won Lee; Jihyoun Lee; Lee Su Kim; Jeong Eon Lee; Sung Yong Kim; Joon Jeong; Sang Ah Han; Sung-Won Kim
Journal:  Breast Cancer Res Treat       Date:  2015-04-12       Impact factor: 4.872

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

8.  Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Authors:  E Warner; W Foulkes; P Goodwin; W Meschino; J Blondal; C Paterson; H Ozcelik; P Goss; D Allingham-Hawkins; N Hamel; L Di Prospero; V Contiga; C Serruya; M Klein; R Moslehi; J Honeyford; A Liede; G Glendon; J S Brunet; S Narod
Journal:  J Natl Cancer Inst       Date:  1999-07-21       Impact factor: 13.506

9.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

10.  Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Authors:  Vahid R Yassaee; Sirous Zeinali; Iraj Harirchi; Soghra Jarvandi; Mohammad A Mohagheghi; David P Hornby; Ann Dalton
Journal:  Breast Cancer Res       Date:  2002-04-16       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.